FAQ
About Optiscan
Q: What is Optiscan?
Optiscan (Optiscan Imaging Ltd; ASX ticker OIL) is an Australian-based global medtech company transforming diagnostics and surgical decision-making through live, in vivo cellular imaging. Our technology eliminates the need for traditional biopsy and slide-based pathology by delivering real-time, high-resolution microscopic images at the point of care. By placing this capability directly in the hands of surgeons, pathologists, and researchers, we’re accelerating decision-making, improving outcomes, and redefining how diseases are studied, detected, and treated.
Q: How did Optiscan begin?
Our technology was born research uundertaken at Monash University, where scientists developed a way to miniaturize complex confocal microscope components using optical fiber. This innovation became the foundation for our fully integrated, miniaturized confocal laser endomicroscopes — designed for use across surgery, pathology, and life sciences.
Q: What is your long-term vision?
Our long-term vision is to make real-time, high-resolution, cellular imaging a standard tool across global healthcare. We aim to lead the future of digital pathology and precision surgeryh through continued innovation in both hardware and software offerings.
Technology and Products
Q: What does Optiscan’s technology do?
Our platform technology enables real-time, non-destructive, 3D, in vivo microscopic imaging at the single-cell level — without the need for biopsy or physical slide preparation. It supports early disease detection, informed surgical decisions, digital pathology, and ethical animal investigations.
Q: Who uses Optiscan’s technology?
- Clinicians – for real-time clinical imaging and early detection.
- Surgeons – for intra-operative cellular imaging and precision surgical guidance.
- Pathologists – to replace traditional slide-based workflows.
- Veterinarians – for minimally invasive diagnostics and animal care.
- Researchers – for live-cell and in vivo imaging in animal models.
Q: What products does Optiscan offer?
- InVivage™ – An intra-oral imaging system for early detection of oral cancer and precancerous leisons.
- InVue™ – A surgical imaging device for real-time surgical decision-making .
- InForm™ – A slide-free digital pathology device for lab-based tissue imaging.
- InSpecta™ – A portable imaging device designed specifically for veterinary medicine.
- ViewnVivo® – A versatiledigital microscope for in vivo cellular imaging in animal models and tissue culture.
Q: What makes Optiscan’s technology unique?
We offer the highest resolution available in the market (0.55µm), real-time focal depth adjustment, and a fully integrated endomicroscopy system — enabling immediate cellular visualization and eliminating the need for invasive or delayed diagnostic processes.
Operations
Q: Where does Optiscan operate?
Our headquarters are in Melbourne, with team members also in Sydney and Perth. We have a U.S. office in Rochester, Minnesota, and a growing presence in Europe and Asia through outsourced sales and distribution partners.
Q: Where are Optiscan products made?
All devices and scanners are manufactured and assembled in our Australian headquarters in Melbourne, Victoria with most components sourced locally or from trusted international suppliers.
Quality, Safety and Sustainability
Q: How does Optiscan ensure product quality?
We adhere to ISO 13485 and FDA quality standards. Every stage of manufacturing involves strict quality checks, from incoming materials to final product release. We also maintain a robust CAPA system and a continuous improvement culture.
Q: What are Optiscan’s sustainability efforts?
We reduce environmental impact through local procurement, promote digital workflows that eliminate physical sample transportation and processing, utilise renewable energy in our operations, undertake recycling initiatives, and pursue ethical sourcing of materials and components. We’re also committed to workplace safety, diversity, and transparent governance.
